Corinne Le Goff's Insider Trades & SAST Disclosures
Corinne Le Goff's most recent trade in Viatris Inc was a trade of 132,493 Restricted Stock Units done . Disclosure was reported to the exchange on March 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Corinne Le Goff.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Viatris Inc | Corinne Le Goff | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 132,493 | 132,493 | - | - | Restricted Stock Units | |
| Viatris Inc | Corinne Le Goff | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 36,721 | 73,441 | - | - | Restricted Stock Units | |
| Viatris Inc | Corinne Le Goff | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 36,721 | 36,721 (0%) | 0% | 0 | Common Stock | |
| Viatris Inc | Corinne Le Goff | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 04 Mar 2025 | 16,276 | 20,445 (0%) | 0% | 9.4 | 152,506 | Common Stock |
| Viatris Inc | Corinne Le Goff | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 1,173 | 21,618 (0%) | 0% | 0 | Common Stock | |
| Viatris Inc | Corinne Le Goff | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 1,172 | 2,344 | - | - | Dividend Equivalent Units | |
| Viatris Inc | Corinne Le Goff | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 04 Mar 2025 | 521 | 21,097 (0%) | 0% | 9.4 | 4,882 | Common Stock |
| Longboard Pharmaceuticals Inc | Corinne Le Goff | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Dec 2024 | 22,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Longboard Pharmaceuticals Inc | Corinne Le Goff | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Dec 2024 | 13,397 | 0 | - | - | Employee Stock Option (right to buy) | |
| Longboard Pharmaceuticals Inc | Corinne Le Goff | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Dec 2024 | 12,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Longboard Pharmaceuticals Inc | Corinne Le Goff | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Dec 2024 | 12,367 | 0 | - | - | Employee Stock Option (right to buy) | |
| Longboard Pharmaceuticals Inc | Corinne Le Goff | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Dec 2024 | 12,367 | 0 | - | - | Employee Stock Option (right to buy) | |
| Longboard Pharmaceuticals Inc | Corinne Le Goff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Viatris Inc | Corinne Le Goff | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 110,162 | 110,162 | - | - | Restricted Stock Units | |
| Viatris Inc | Corinne Le Goff | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 78,688 | 78,688 | - | - | Restricted Stock Units | |
| Longboard Pharmaceuticals Inc | Corinne Le Goff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Imunon Inc | Corinne Le Goff | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 90,000 | 320,000 | - | - | Stock Option (Right to Buy) | |
| Imunon Inc | Corinne Le Goff | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2022 | 177,000 | 177,000 | - | - | Stock Option (Right to Buy) | |
| Imunon Inc | Corinne Le Goff | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2022 | 53,000 | 53,000 (0%) | 0% | 0 | Common Stock | |
| Longboard Pharmaceuticals Inc | Corinne Le Goff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 12,367 | 12,367 | - | - | Stock Option (Right to Buy) | |
| Longboard Pharmaceuticals Inc | Corinne Le Goff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 13,397 | 13,397 | - | - | Stock Option (Right to Buy) | |
| Longboard Pharmaceuticals Inc | Corinne Le Goff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 12,367 | 12,367 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Corinne Le Goff | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 58,563 | 58,563 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Corinne Le Goff | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 25,400 | 25,400 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges